With regard to your bullet points (subject to policy and testing regime):

• As a prescribed medicine, it would have to be disclosed before testing - yes it would need to be disclosed

• It has a very low THC level and should not show up in the screening tool/test. 99% of the time it doesn’t, but if the doses increase as the person requires more it could.The CBD products are defined as having less than 2% THC

• It should be treated exactly the same as any prescribed medicines. If it says “May create drowsiness or do not operate heavy machinery” then you shouldn’t.that's correct. it's all about ensuring people can work safely

• Not all doctors can prescribe Medicinal Marijuana at the moment Although the legislation initially proposed the need for a specialist sign-off, the regulations, now in place, technically allow all general medical practitioners to prescribe medicinal cannabis to their patients.
• Medicinal Marijuana is not yet subsidised by Pharmac this is not something I can answer

Hi everyone, I am a partner working in the employment and health and safety at Wynn Williams and will be answering your questions. Over recent years, we have had a high involvement in both preparing, and enforcing, drug and alcohol policies. We developed a real expertise in this over the Canterbury earthquakes, as it was a real focus in many industries. The next instalment is the proposed referendum later this year. We have already had a lot on inquiry (in between covid-19 issues!) about how any changes, due to the referendum, might impact on drug and alcohol policies. I have also spoken at conferences already on this topic. I'm happy to answer your questions on how the upcoming referendum could impact the drug and alcohol policy for your organisation.